Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 221059
Company: AZURITY PHARMACEUTICALS INC

Products on NDA 221059

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
EDARAVONE	EDARAVONE	105MG/5ML	SOLUTION;ORAL	Prescription	None	No	No

Approval Date(s) and History, Letters, Labels, Reviews for NDA 221059

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
07/17/2026	ORIG-1	Tentative Approval	Type 3 - New Dosage Form	STANDARD	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/221059Orig1s000TAltr.pdf